Fundus Camera Market Size, Share, Future Analysis, 2026-2034

Market Overview

According to fortune business insights, the global fundus camera market size was valued at USD 654.08 million in 2025. The market is projected to grow from USD 691.51 million in 2026 to USD 1,116.81 million by 2034, exhibiting a CAGR of 6.18% during the forecast period. North America dominated the fundus camera market with a market share of 36.40% in 2025.

The analysis shows that the market is driven by the increasing incidence of eye diseases such as diabetic retinopathy, age-related macular degeneration (AMD), and glaucoma. Fundus photography is crucial for diagnosing and monitoring these conditions, which is expected to drive its usage in eye care settings. For instance, the National Center for Biotechnology Information (NCBI) estimated in November 2021 that 22.2% of people with diabetes globally have diabetic retinopathy, indicating a strong clinical need for these devices.

Major Players Profiled in the Market Report:

• Carl Zeiss Meditech AG (Germany)

• Kowa Company, Ltd. (Japan)

• Optomed (Finland)

• Topcon Corporation (Japan)

• NIDEK CO., LTD. (Japan)

• Haag-Streit Group (Switzerland)

• CANON MEDICAL SYSTEMS CORPORATION (Japan)

• Mediworks (China)

• Visionix (France)

Segments

Key Advantages to Surge Adoption of Non-Mydriatic CamerasBased on product type, the market is classified into non-mydriatic cameras, mydriatic cameras, and others. The non-mydriatic cameras segment is expected to hold a significant market share as these devices can capture retinal images without pupil dilation, offering a faster and more patient-friendly experience.

Ease of Use to Drive Handheld Cameras Segment GrowthBy portability, the market is classified into tabletop and handheld. The handheld cameras segment is expected to lead and grow significantly due to its portability and ease of use, making it ideal for remote diagnosis and screenings for conditions like diabetic retinopathy.

Rising Incidence to Propel Diabetic Retinopathy SegmentBased on indication, the market is divided into diabetic retinopathy, glaucoma, age-related macular degeneration (AMD), and others. The diabetic retinopathy segment holds a substantial market share, driven by the rising global incidence of the condition, which is projected to affect 190.0 million people by 2030.

Increase in Patient Visits to Boost Hospitals Segment GrowthBy end-user, the market is segmented into hospitals, ophthalmic clinics, and others. The hospitals segment dominated the market owing to the high volume of eye examinations performed in these settings for diagnosing and monitoring various ocular conditions.

Geographically, the market is studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

For detailed market insights: https://www.fortunebusinessinsights.com/fundus-cameras-market-105020

Report Coverage

The report offers:

• Major growth drivers, restraining factors, opportunities, and potential challenges for the market.

• Comprehensive insights into regional developments.

• List of major industry players.

• Key strategies adopted by the market players, including partnerships and new product launches.

• The latest industry developments including product launches, partnerships, and regulatory approvals.

Drivers & Restraints

Rising Prevalence of Ophthalmic Disorders to Propel Market ExpansionThe rapid growth in the aging population and the rising prevalence of ocular diseases such as diabetic retinopathy, AMD, and glaucoma are key market drivers. As the global geriatric population grows, more patients are seeking ophthalmic diagnoses, increasing the demand for effective diagnostic tools like fundus cameras.

However, the high cost of these devices may hamper market growth. Advanced models can range from USD 10,000 to USD 50,000, making them financially inaccessible for smaller clinics and healthcare facilities, particularly in low-income regions. This price barrier can limit the adoption of essential diagnostic tools.

Regional Insights

High Burden of Eye Conditions in the U.S. Propels Market Growth in North AmericaNorth America holds the dominant fundus camera market share and is projected to maintain its lead. The region’s growth is attributed to the high volume of ophthalmic diagnoses, a well-established healthcare infrastructure, and the growing burden of eye conditions like diabetic retinopathy in the U.S.

Asia Pacific is expected to be the fastest-growing region in the market. This growth is driven by the increasing focus of market players on implementing large-scale eye screening programs, often integrating advanced, cost-effective technologies like smartphone-based fundus cameras.

Fundus Camera Market Future Growth

The fundus camera market is experiencing transformative growth, fueled by technological advancements, particularly the integration of Artificial Intelligence (AI) and the expansion of telemedicine. AI-powered fundus cameras enhance image analysis, enabling faster and more accurate detection of eye diseases, which is critical in areas with limited access to specialists. The increased use of portable fundus cameras in telemedicine is also revolutionizing remote diagnostics, allowing specialists to diagnose conditions from afar. This trend is expanding the customer base, especially in rural and underserved areas, presenting significant growth opportunities for the market.

Competitive Landscape

Key Players Focus on Strategic Initiatives to Boost Market ShareThe global market is consolidated, with major players such as Carl Zeiss Meditech AG, Topcon Corporation, and NIDEK CO., LTD. holding a significant market share. These companies maintain their dominance through strong global distribution networks and a wide range of innovative products. Key strategies include launching technologically advanced products, forming strategic partnerships, and expanding into untapped markets to strengthen their competitive position.

Key Industry Development

• December 2024: AVANT Technology and Ainnova Tech announced plans to develop a fundus camera with AI software for early disease detection.

• September 2024: Topcon Corporation received FDA 510(k) clearance for OCTA on its robotic Maestro2, the first robotic OCT color fundus camera system with OCTA available in the U.S.

• March 2023: Remidio Innovative Solutions Pvt Ltd. obtained CE mark approval for its Medios AI, an algorithm to detect Referable diabetic retinopathy that can be used with both desktop and smartphone-based fundus cameras.

Curious About Japan’s Market? Explore the Latest Fundus Camera Market Insights